Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial.
暂无分享,去创建一个
[1] Sharon E Straus,et al. Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial , 2005, Canadian Medical Association Journal.
[2] A. Donner,et al. Randomization by cluster. Sample size requirements and analysis. , 1981, American journal of epidemiology.
[3] N. Freemantle,et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey , 2002, The Lancet.
[4] S. Yusuf,et al. Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .
[5] S. Majumdar,et al. Evaluating and Improving Physician Prescribing , 2002 .
[6] K. Teo,et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). , 2002, Archives of internal medicine.
[7] W. Tierney,et al. Comparing methods to identify general internal medicine clinic patients with chronic heart failure. , 2001, American heart journal.
[8] J. Hampton,et al. PREVALENCE OF ANGINA AS ASSESSED BY A SURVEY OF PRESCRIPTIONS FOR NITRATES , 1988, The Lancet.
[9] Eugene Vayda,et al. Opinion leaders vs audit and feedback to implement practice guidelines. Delivery after previous cesarean section. , 1991, JAMA.
[10] S B Soumerai,et al. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. , 1998, JAMA.
[11] G. Braunstein,et al. Meta-Analysis: Angiotensin-Receptor Blockers in Chronic Heart Failure and High-Risk Acute Myocardial Infarction , 2004, Annals of Internal Medicine.
[12] K. Shojania,et al. Evidence-based quality improvement: the state of the science. , 2005, Health affairs.
[13] F. McAlister,et al. The Treatment and Prevention of Coronary Heart Disease in Canada: Do Older Patients Receive Efficacious Therapies? , 1999 .
[14] C. McDonald,et al. Effects of computerized guidelines for managing heart disease in primary care , 2003, Journal of General Internal Medicine.
[15] Y. Pirson,et al. CYCLOSPORIN-DILTIAZEM INTERACTION , 1986, The Lancet.
[16] Ian Graham,et al. Evidence-based medicine and the practicing clinician , 1999, Journal of General Internal Medicine.
[17] J Gabbay,et al. Understanding the role of opinion leaders in improving clinical effectiveness. , 2001, Social science & medicine.
[19] S. Majumdar,et al. Controlled trial of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes. , 2003, Diabetes care.
[20] P. Passmore,et al. The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention: a cross‐sectional study in general practice , 2002, Pharmacoepidemiology and drug safety.
[21] J. Grimshaw,et al. Implementation Science BioMed Central Study protocol , 2006 .
[22] D. Wood,et al. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries , 2001, The Lancet.
[23] P G Shekelle,et al. Are nonspecific practice guidelines potentially harmful? A randomized comparison of the effect of nonspecific versus specific guidelines on physician decision making. , 2000, Health services research.
[24] E. McGlynn,et al. Measuring Quality of Care , 1996 .
[25] C. Furberg,et al. From knowledge to practice in chronic cardiovascular disease: a long and winding road. , 2004, Journal of the American College of Cardiology.
[26] S. Derose,et al. Point-of-Service reminders for prescribing cardiovascular medications. , 2005, The American journal of managed care.
[27] F. McAlister,et al. A cluster randomized trial to assess the impact of opinion leader endorsed evidence summaries on improving quality of prescribing for patients with chronic cardiovascular disease: rationale and design [ISRCTN26365328] , 2005, BMC cardiovascular disorders.
[28] Randall S Stafford,et al. The underutilization of cardiac medications of proven benefit, 1990 to 2002. , 2003, Journal of the American College of Cardiology.
[29] J. Tu,et al. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces. , 2005, The Canadian journal of cardiology.
[30] Jeroan J. Allison,et al. Do Local Opinion Leaders Augment Hospital Quality Improvement Efforts?: A Randomized Trial to Promote Adherence to Unstable Angina Guidelines , 2003, Medical care.
[31] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[32] W. Gibler,et al. Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE). , 2005, The American journal of cardiology.